First, while our findings were validated across multiple databases and reinforced by in vitro functional assays in two COAD cell lines, the lack of in vivo validation using animal models limits the ability to fully assess the physiological relevance and therapeutic potential of GNAI1 and GNAI2 in a more complex tumor microenvironment. The gene discussed is GNAI1; the disease is neoplasm.